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The mechanisms that govern intracellular transport of sterols in eukaryotic cells are not well understood. Saccharomyces
cerevisiae is a facultative anaerobic organism that becomes auxotroph for sterols and unsaturated fatty acids in the absence
of oxygen. To identify pathways that are required for uptake and transport of sterols, we performed a systematic screen
of the yeast deletion mutant collection for genes that are required for growth under anaerobic conditions. Of the 4800
nonessential genes represented in the deletion collection, 37 were essential for growth under anaerobic conditions. These
affect a wide range of cellular functions, including biosynthetic pathways for certain amino acids and cofactors,
reprogramming of transcription and translation, mitochondrial function and biogenesis, and membrane trafﬁcking.
Thirty-three of these mutants failed to grow on lipid-supplemented media when combined with a mutation in HEM1,
which mimics anaerobic conditions in the presence of oxygen. Uptake assays with radio- and ﬂuorescently labeled
cholesterol revealed that 17 of the 33 mutants strongly affect uptake and/or esteriﬁcation of exogenously supplied
cholesterol. Examination of the subcellular distribution of sterols in these uptake mutants by cell fractionation and
ﬂuorescence microscopy indicates that some of the mutants block incorporation of cholesterol into the plasma membrane,
a presumably early step in sterol uptake. Unexpectedly, the largest class of uptake mutants is affected in mitochondrial
functions, and many of the uptake mutants show electron-dense mitochondrial inclusions. These results indicate that a
hitherto uncharacterized mitochondrial function is required for sterol uptake and/or transport under anaerobic conditions
and are discussed in light of the fact that mitochondrial import of cholesterol is required for steroidogenesis in vertebrate
cells.
INTRODUCTION
Sterols are important lipid components of eukaryotic mem-
branes that determine different membrane characteristics
important for membrane transport and sorting in animal,
plant, and fungal cells (Liscum and Dahl, 1992; Maxﬁeld and
Wustner, 2002; Soccio and Breslow, 2004).
Either lack or excess of cellular sterols is detrimental,
necessitating mechanisms that control sterol homeostasis at
different levels, from its synthesis, storage in form of steryl
esters, to its release and appropriate distribution between
subcellular membranes. Cholesterol is synthesized in the
endoplasmic reticulum (ER) and transported to the plasma
membrane, which harbors90% of the free sterol pool of the
cell (Lange et al., 1989). ER-to-plasma membrane transport of
cholesterol is temperature and energy dependent but only
partially sensitive to brefeldin A, suggesting that both ve-
sicular and nonvesicular transport pathways may be oper-
ating (Kaplan and Simoni, 1985; Urbani and Simoni, 1990;
Puglielli et al., 1995; Smart et al., 1996; Field et al., 1998; Heino
et al., 2000).
Fungal cells synthesize ergosterol instead of cholesterol as
their main sterol and many aspects of sterol homeostasis are
conserved between yeast and human (Sturley, 2000). Under
aerobic conditions, ergosterol is synthesized in the ER mem-
brane and is greatly enriched at the yeast plasma membrane
(Schneiter et al., 1999). Under these conditions, cells do not
take up exogenous sterols, a phenomenon known as “aero-
bic sterol exclusion.” Under anaerobic growth conditions or
in mutants that lack heme, however, yeast becomes auxo-
trophic for sterols and unsaturated fatty acids, because the
synthesis of these lipids requires molecular oxygen (An-
dreasen and Stier, 1953; Lewis et al., 1985). The fact that
Saccharomyces cerevisiae is a facultative anaerobic organism
that displays robust growth when appropriately supple-
mented indicates that lipid uptake is efﬁcient. The cellular
processes that are required for sterol uptake and the mech-
anisms that regulate sterol homeostasis under conditions
where de novo synthesis is bypassed, however, are not well
understood (Lorenz et al., 1986).
Under aerobic conditions, yeast cells bypass the aerobic
sterol exclusion if they bear a hypermorphic allele of the
transcription factor UPC2 or in its homologue ECM22, or if
they overexpress the transcriptional regulator Sut1p (Lewis
et al., 1988; Bourot and Karst, 1995; Crowley et al., 1998).
These conditions result in the up-regulation of two ATP-
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binding cassette (ABC) transporters, Aus1p and Pdr11p, and
a putative cell wall mannoprotein, Dan1 (Wilcox et al., 2002;
Alimardani et al., 2004). Consistent with a role of Aus1p and
Pdr11p in sterol uptake, an aus1 pdr11 double mutant
does not grow under anaerobic conditions and has a greatly
reduced rate of steryl ester formation (Wilcox et al., 2002; Li
and Prinz, 2004). A defect in sterol uptake and impaired
growth under anaerobic conditions was also observed in
cells that lack ARV1, a gene that is required for viability of
cells that lack steryl esters (Tinkelenberg et al., 2000). ARV1
encodes a conserved protein with six putative transmem-
brane domains and localizes to the ER and Golgi membranes
(Swain et al., 2002).
To identify cellular processes that are important for sterol
uptake, transport, and homeostatic regulation in the absence
of its de novo synthesis, we screened the yeast deletion
mutant collection for genes that are required for growth
under anaerobic conditions. Here, we report the identiﬁca-
tion and preliminary characterization of a novel set of po-
tential sterol uptake/transport mutants. Further character-
ization of the pathways that are affected in these mutants is
likely to provide important new insights into the mecha-
nisms that regulate sterol uptake, transport, and homeosta-
sis in yeast and possibly also in mammalian cells.
MATERIALS AND METHODS
Yeast Strains and Growth Conditions
The yeast strains used in this study are shown in Table 1. The haploid gene
deletion collections in the BY4742 background (MAT his31 leu20 ura30
lys20) and BY4741 background (MATa his31 leu20 ura30 met150) were
obtained from EUROSCARF (Winzeler et al., 1999). Strains were cultivated in
YPD rich media (1% Bacto yeast extract, 2% Bacto peptone [US Biological,
Swampscott, MA], and 2% glucose) or minimal media (0.67% yeast nitrogen
base without amino acids [US Biological], 2% glucose, and 2 g/l amino acids).
Media supplemented with sterols and fatty acids contained 5 mg/ml Tween
80 and 20 g/ml ergosterol or cholesterol (Sigma-Aldrich, St. Louis, MO).
hem1 mutant cells were supplemented with 10 g/ml -aminolevulinic acid
(ALA). The colony forming capacity of hem1 double mutant cells was
determined by plating cells after 24, 48, or 72 h of growth on sterol-supple-
mented YPD plates containing ALA or Tween 80 and cholesterol. Cell viabil-
ity was determined by staining cells with 0.1% methylene blue. Selection for
the kanMX4 marker was on media containing 200 g/ml G418 (Invitrogen,
Carlsbad, CA). Anaerobic conditions were maintained using an anaerobic jar
containing an AnaeroGen sachet (Oxoid, Basingstoke, Hampshire, England).
Yeast was transformed by lithium acetate (Ito et al., 1983). For DNA cloning
and propagation of plasmids, Escherichia coli strain XL1-Blue (Stratagene,
La Jolla, CA) was used.
Plasmid Constructions and DNA Manipulations
The plasmid pHEM1-LEU2 containing the hem1::LEU2 disruption cassette
(kindly provided by I. Hapala, Slovak Academy of Sciences, Bratislava, Slo-
vak Republic) was cut with BamHI/HindIII to release the disruption cassette,
and yeast transformants were selected on minimal media without leucine but
supplemented with ALA. Correct insertion of the disruption cassette at the
HEM1 locus was conﬁrmed by phenotypic analysis of the transformants, i.e.,
growth on ALA-supplemented media but no growth on nonsupplemented
media. Plasmids expressing the functional, green ﬂuorescent protein (GFP)-
tagged versions of Aus1p (pW1220) and Pdr11p (pWP1251) were kindly
provided by W. Prinz (NIH, Bethesda, MD) (Li and Prinz, 2004). The plasmid
for overexpression of Aus1p (pNEV-AUS1) was kindly provided by T. Berges
(University Poitiers, Poitiers, France) (Alimardani et al., 2004).
Cholesterol Uptake
Uptake of [14C]cholesterol was performed essentially as described previously
(Crowley et al., 1998). hem1 mutant cells were cultured in ALA-containing
media, washed, and then diluted in minimal media supplemented with
Tween 80 (5 mg/ml), cholesterol (20 g/ml), and 0.025 Ci/ml [14C]choles-
terol (American Radiolabeled Chemicals, St. Louis, MO) and cultivated for 24
or 48 h at 24°C. Equal optical density (OD) units of cells were collected and
washed with 0.5% tergitol. [3H]Palmitic acid was added to the cell pellet as
internal standard. Cells were disrupted with glass beads in the presence of
chloroform/methanol (1:1), and lipids were extracted into the organic phase.
Lipids were separated by thin-layer chromatography (TLC) (Merck, Darm-
stadt, Germany) with the solvent system petroleum ether/diethyl ether/
acetic acid (70:30:2; per volume) and free cholesterol and cholesteryl esters
were quantiﬁed by scanning with a Tracemaster 40 automatic TLC-linear
analyzer (Berthold Technologies, Bad Wildbad, Germany). TLC plates were
then exposed to a phosphorimager screen and visualized using a Phospho-
rImager (Bio-Rad, Hercules, CA). Lipid extracts containing 25-{N-[(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)-methyl]amino}-27-norcholesterol (NBD-choles-
terol) were visualized using a FluorChem 8900 imaging system (Alpha
Innotech, San Leandro, CA).
Fluorescence Microscopy
To visualize uptake of NBD-cholesterol (Avanti Polar Lipids, Alabaster, AL)
hem1 mutant cells were incubated with a 1:1 mixture of cholesterol and
NBD-cholesterol (20 g/ml) in Tween 80 (5 mg/ml). Cells were collected after
24 h of incubation at 24°C, washed with minimal media containing 1 mg/ml
p-phenylenediamine as antibleach, and examined by ﬂuorescence microscopy
using a Plan-Neoﬂuor objective (100, numerical aperture 1.3) on a Zeiss
Axioplan 2 (Carl Zeiss, Oberkochen, Germany) equipped with an AxioCam
charge-coupled device camera and AxioVision 4.2 software. Intracellular lipid
particles were stained with Nile red. Vacuoles were stained with FM4-64.
Pictures were recorded with equal exposure times, processed to maintain
intensity differences, and mounted using Adobe Photoshop CS (Adobe Sys-
tems, Mountain View, CA).
Electron Microscopy
For ultrastructural examination, heme-deﬁcient mutant cells were cultivated
in media containing ALA and then diluted into Tween 80 and cholesterol-
supplemented media. Cells were cultivated for 24 h at 24°C and then ﬁxed in
1.5% aqueous solution of KMnO4 for 30 min at room temperature. Fixed cells
were washed several times in distilled water and incubated in 0.5% aqueous
uranyl acetate overnight with shaking at 4°C. Samples were dehydrated in a
graded series of ethanol (50–100%) and embedded in Spurr resin. Ultrathin
sections (80 nm) were stained with lead citrate and viewed with a Philips CM
10 electron microscope.
Table 1. S. cerevisiae strains used in this study
Strain Relevant genotype Source or reference
BY4742 MAT his31 leu20 ura30 lys20 EUROSCARF; Winzeler et al. (1999)
MAT his31 leu20 ura30 lys20 xyz::kanMX4 EUROSCARF; Winzeler et al. (1999); xyz indicates a
deletion in a nonessential gene used in this study
MAT his31 leu20 ura30 lys20 xyz::kanMX4 hem1::LEU2 This study, heme-deﬁcient xyz-double mutant strains
YRS1707 MAT his31 leu20 ura30 lys20 hem1::LEU2 This study
YRS1945 MAT? his31 leu20 ura30 lys20 aus1::kanMX4
pdr11::kanMX4
This study
YRS1962 MAT? his31 leu20 ura30 lys20 aus1::kanMX4
pdr11::kanMX4 hem1::LEU2
This study
YRS1851 MAT his31 leu20 ura30 lys20 are1::kanMX4
are2::HIS3MX6 hem1::LEU2
This study
YRS2135 MAT his31 leu20 ura30 lys20 atf2::kanMX4 hem1::LEU2 This study
YRS2114 MAT his31 leu20 ura30 lys20 hem1::LEU2
ERG6-RFP-kanMX6
This study
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Subcellular Fractionation and Western Blot Analysis
To determine the sterol distribution in subcellular membranes, heme-deﬁcient
mutant cells were cultivated in minimal media supplemented with Tween 80
(5 mg/ml), cholesterol (20 g/ml), and 0.25 Ci/ml [14C]cholesterol for 24 h
at 24°C. Cells were converted to spheroplasts, and the homogenate was
fractionated on an Accudenz density gradient (Accurate Chemical & Scien-
tiﬁc, Oslo, Norway) as described previously (Cowles et al., 1997). Twelve
fractions were collected from the top of the gradient; lipids were extracted
and analyzed by TLC, proteins were precipitated with 10% trichloroacetic
acid, and marker proteins were detected by Western blot analysis. Protein
concentration was determined by the method of Lowry, using bovine serum
albumin as standard. Radiolabeled cholesterol was determined by scintilla-
tion counting. Western blot analyses to determine the distribution of marker
proteins in Accudenz gradient fractions were performed with the following
rabbit antibodies: anti-Sec61p (1:5000; R. Schekman, University of California,
Berkeley, Berkeley, CA), anti-Gas1p (1:5000; A. Conzelmann, University of
Fribourg, Fribourg, Switzerland), anti-porin (1:10,000; G. Daum, Graz Univer-
sity of Technology, Graz, Austria), anti-Erg6p (1:10,000; G. Daum, Graz Uni-
versity of Technology), anti-Tlg1p (1:5000; H. Pelham, MRC Laboratory of
Molecular Biology, Cambridge, United Kingdom), anti-Pma1p (1:10,000), or
anti-CPY (1:10,000). Rabbit antibodies against GFP (1:5000; Torrey Pines Bio-
labs, Houston, TX) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (1:10,000) were used to examine the expression of the GFP-tagged
ABC transporters in the sterol uptake mutants.
RESULTS
To identify genes that are required for the uptake and intra-
cellular transport of sterols, we screened the haploid yeast
deletion mutant collection containing 4800 strains for mu-
tants that fail to grow under anaerobic conditions on YPD
media supplemented with the fungal-speciﬁc sterol ergos-
terol or the mammalian sterol cholesterol and Tween 80 as a
source of unsaturated fatty acids (Winzeler et al., 1999). The
maintenance of oxygen-limiting conditions during these
growth tests was assessed by ensuring that wild-type cells
did not grow on media lacking the lipid supplementation
(Figure 1). Candidate mutants that displayed weak growth
in the ﬁrst round of screening were retested four to ﬁve
times to conﬁrm their growth phenotype under anaerobic
conditions. Linkage of the phenotype to the gene disruption
was conﬁrmed by examining mutant strains from the dele-
tion mutant collection of the opposite mating type and by
PCR analysis with gene-speciﬁc primers (our unpublished
data). Only mutants that displayed the anaerobic growth
phenotype in both mating types remained in the mutant
collection.
Ergosterol supports a number of different cellular pro-
cesses, including cell cycle progression (known as the spark-
ing function of ergosterol), cell polarization, membrane fu-
sion during mating, endocytosis and vacuolar fusion, and
sorting of the tryptophan permease along the secretory path-
way (Rodriguez and Parks, 1983; Rodriguez et al., 1985;
Munn et al., 1999; Kato and Wickner, 2001; Bagnat and
Simons, 2002; Umebayashi and Nakano, 2003). Under the
growth conditions used here, these processes did not be-
come growth limiting as indicated by the fact that wild-type
cells grew equally well on media supplemented with cho-
lesterol or ergosterol. However, eight of the mutants identi-
ﬁed in this screen (aro2, aro7, tkl1, adh1, rib4, drs2,
pho85, and ypk1) displayed reduced growth on media
containing cholesterol compared with ergosterol, suggesting
that these mutants have a more stringent requirement for
ergosterol in a growth limiting process that is not satisﬁed
by cholesterol (Figure 1). The aus1 pdr11 double mutant
was included in this and all subsequent assays as a control,
known to be defective in sterol uptake (Wilcox et al., 2002; Li
and Prinz, 2004).
The 37 mutants that showed a growth defect under an-
aerobic conditions were classiﬁed according to the function
of the gene defective in the respective strain. As shown in
Table 2, these mutants affect various cellular functions: nine
bear deﬁciencies in the metabolism of amino acids, vitamins,
and cofactors, ﬁve affect transcription and translation, three
affect vesicular transport, and three bear defects in protein
kinases. The largest class of mutants with 11 members, how-
ever, affects mitochondrial functions; ﬁve of these directly
impair the F1 subunit of the ATP synthase. Under anaerobic
conditions, F1-catalyzed ATP hydrolysis is required to
maintain an electrochemical potential across the inner mito-
chondrial membrane, which is essential for mitochondrial
biogenesis (Lefebvre-Legendre et al., 2003). Mutations in
GUP1 and NUP84 affect glycerol transport and nuclear im-
port, respectively, and SHE1 affects cell growth when over-
expressed (Espinet et al., 1995). Three of the mutants bear
deletions of functionally uncharacterized open reading
frames, all of which affect growth on nonfermentable carbon
sources and hence are required for respiration (YBL100,
YJR120, and YLR202) (Entian et al., 1999; Dimmer et al.,
2002). Together, the results of these analyses indicate that
various cellular processes are differentially regulated under
anaerobic conditions and become essential under oxygen-
limiting conditions.
Characterization of the Anaerobic Nonviable Mutants in
a Heme-deﬁcient Background
Deﬁciency in heme biosynthesis mimics anaerobic condi-
tions in the presence of oxygen (Gollub et al., 1977). We thus
examined whether disruption of HEM1 in the anaerobic
nonviable mutants results in growth arrest on sterol-supple-
mented media as would be predicted for mutants that fail to
Figure 1. Identiﬁcation of genes that are essential for growth un-
der anaerobic conditions. Cells bearing a deletion of the gene indi-
cated were serially diluted 10-fold and spotted on YPD media
containing cholesterol (Chol/Tw) or ergosterol (Erg/Tw) and
Tween 80 or on nonsupplemented YPD media (Non-suppl.). Plates
were incubated under anaerobic or aerobic conditions for 4 d at
30°C. Anaerobic growth of wild-type (BY4742) and nongrowth of an
aus1 pdr11 (YRS1945) double mutant strain is shown for compar-
ison on the top two lines.
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take up sterols. The lack of HEM1 can be overcome either by
supplementing cells with sterols and unsaturated fatty acids
or it can be bypassed by providing the enzymatic product of
the Hem1p-catalyzed ﬁrst step in heme biosynthesis, ALA
(Gollub et al., 1977). Using a disruption cassette forHEM1, 33
of the 37 mutants could be obtained in a heme-deﬁcient
background. For rib1, rlr1, sla2, and atp3 double mu-
tants with hem1 could not be obtained despite repeated
attempts.
Growth analysis of the heme-deﬁcient mutants under aer-
obic conditions on sterol-supplemented media revealed that
most of the mutants were unable to grow when supple-
mented with either ergosterol or cholesterol and Tween 80,
but they were rescued by ALA (Figure 2). This phenotype is
thus consistent with a possible defect in sterol uptake/
transport in these mutants. Moreover, the observation that
the mutants were not viable in a heme-deﬁcient background
suggests that their growth defect under anaerobic conditions
is due to a deﬁciency of a heme-dependent reaction. hom6,
ypk1, and aco1 mutants displayed some growth on lipid-
supplemented media, but they did not reach the growth
capacity of wild-type cells and thus remained in the collec-
Table 2. Genes required for growth under anaerobic conditions
Functional class ORF Gene Function
Amino acid metabolism YGL148 ARO2 Chorismate synthase; required for biosynthesis of aromatic amino
acids
YPR060 ARO7 Chorismate mutase; required for biosynthesis of tyrosine and
phenylalanine
YJR139 HOM6 Homoserine dehydrogenase; required for biosynthesis of
methionine and threonine
YOR184 SER1 Phosphoserine transaminase; required for biosynthesis of l-serine
YPR074 TKL1 Transketolase I; required for the pentose phosphate pathway and
for biosynthesis of aromatic amino acids
Fermentation of glucose and metabolism of
cofactors
YOL086 ADH1 Alcohol dehydrogenase; required for glucose fermentation and
catabolism of tryptophan and phenylalanine
YOR209 NPT1 Nicotinate phosphoribosyltransferase; required for salvage
pathway of NAD biosynthesis, affects silencing
YBL033 RIB1 GTP cyclohydrolase II; required for riboﬂavin, FMN, and FAD
biosynthesis
YOL143 RIB4 Riboﬂavine synthase; required for riboﬂavin, FMN, and FAD
biosynthesis
Regulation of transcription and translation YKL139 CTK1 RNA polymerase II C-terminal domain kinase
YML112 CTK3 RNA polymerase II C-terminal domain kinase
YNL139 RLR1 RNA polymerase II transcription elongation, mRNA export
YBL093 ROX3 RNA polymerase II holoenzyme component
YGL135 RPL1B Structural constituent of the large (60S) ribosomal subunit
Vesicular transport YAL026 DRS2 P-type ATPase, potential aminophospholipid translocase
YNL243 SLA2 Protein involved in membrane cytoskeleton assembly, required
for cell polarization and endocytosis
YLR240 VPS34 Phosphatidylinositol 3-kinase, required for vacuolar protein
sorting
Protein kinases YLR226 BUR2 Cyclin-dependent protein kinase regulator
YPL031 PHO85 Cyclin-dependent protein kinase, regulates glycogen and
phosphate metabolism
YKL126 YPK1 Serine/threonine protein kinase required for endocytosis
Mitochondrial function and biogenesis YLR304 ACO1 Aconitase; required for TCA cycle, mutation leads to glutamate
auxotrophy
YBL099 ATP1 -Subunit of F1 sector of F1F0 ATP synthase
YJR121 ATP2 -Subunit of F1 sector of F1F0 ATP synthase
YBR039 ATP3 -Subunit of F1 sector of F1F0 ATP synthase
YNL315 ATP11 Molecular chaperone required for assembly of F1 sector of the
F1F0 ATP synthase
YJL180 ATP12 Molecular chaperone required for assembly of F1 sector of the
F1F0 ATP synthase
YOR125 CAT5 May encode a protein involved in one or more mono-oxygenase
or hydroxylase steps of ubiquinone biosynthesis
YJR144 MGM101 Involved in mitochondrial genome maintenance
YLR369 SSQ1 Chaperon involved in the synthesis and assembly of iron/sulfur
clusters into proteins
YDR470 UGO1 Outer membrane protein required for mitochondrial fusion
YPR024 YME1 Mitochondrial inner membrane peptidase
Miscellaneous YGL084 GUP1 Multimembrane-spanning protein and putative glycerol
transporter that is essential for proton symport of glycerol
YDL116 NUP84 Subunit of the nuclear pore complex
YBL031 SHE1 Cytoskeletal protein of unknown function; overexpression causes
growth arrest
Unknown function YBL100 Dubious open reading frame
YJR120 Hypothetical open reading frame
YLR202 Dubious open reading frame
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tion for further analysis of a possible lipid uptake defect.
Other mutants, such as aro2, aro7, tkl1, and rib4 grew
signiﬁcantly better on ergosterol- than on cholesterol-sup-
plemented media and hence maintained their preference for
ergosterol over cholesterol even in the heme-deﬁcient back-
ground.
Growth Characteristics of Heme-deﬁcient Mutants
To examine a possible defect of these mutants in sterol
uptake/transport in liquid media, we examined growth and
viability of the heme-deﬁcient mutants in liquid media that
either contained or lacked cholesterol. Therefore, cells were
grown in ALA-supplemented minimal media and then di-
luted into media with or without cholesterol. Under these
conditions, the hem1 mutant and even an uptake-deﬁcient
aus1 pdr11 hem1 triple mutant continued to grow and
reached stationary phase within 24 h of growth, irrespective
of whether the media contained cholesterol (Figure 3A).
Plating the cells on rich media containing ALA revealed that
the uptake deﬁcient aus1 pdr11 hem1 triple mutant be-
gins to loose viability after 48 h (Figure 3B). Examination of
the growth properties of the strains from the mutant collec-
tion revealed that the majority of these heme-deﬁcient dou-
ble mutants reached the stationary phase, albeit only within
48 h. Only the strains lacking NPT1, ROX3, ADH1, or DRS2
grew more slowly and did not reach an OD above 2 (Figure
3C). When plated from the liquid culture on solid media
supplemented with ALA, the majority of mutants retained
their capacity to grow colonies from single cells. Only npt1,
and adh1, and to a much lesser degree vps34, lost viability
in the cholesterol media (Figure 3D). Because of their slow
growth and low viability, npt1 and adh1 were excluded
from the collection and not further analyzed. The estimates
of cell viability based on plating correlated well with those
obtained by staining cells with a vital dye, methylene blue
Figure 2. Characterization of anaerobic nonviable mutants in a
heme-deﬁcient background. Heme-deﬁcient cells of the indicated
genotype were serially diluted 10-fold and spotted on YPD media
containing cholesterol (Chol/Tw) or ergosterol (Erg/Tw) and
Tween 80, YPD media containing ALA (ALA), and on nonsupple-
mented YPD media (Non-suppl.). Plates were incubated under aer-
obic conditions for 4 d at 30°C. Growth of a hem1 (YRS1707) and
nongrowth of an aus1 pdr11 hem1 (YRS1962) triple mutant strain
is shown for comparison on the top two lines.
Figure 3. Growth and viability of heme-deﬁcient mutants in cho-
lesterol-supplemented media. (A) Growth of hem1 (YRS1707) and
an aus1 pdr11 hem1 (YRS1962) mutant in media with or without
cholesterol. Cells of the indicated genotype were pre-grown in
minimal media supplemented with ALA, washed, and then diluted
into media with (C T) or without cholesterol and Tween 80 (C
T). Cell growth was monitored by reading absorbance at 600 nm.
(B) Viability of heme-deﬁcient wild-type and aus1 pdr11 sterol
uptake mutant. Cells of the indicated genotype were grown as
described for A. Aliquots were diluted and plated on solid rich
media containing ALA. The number of colony-forming units per
OD unit of culture over time is shown. (C) Growth of the anaerobic
nonviable mutants. Heme-deﬁcient cells of the indicated genotype
were cultivated as described for panel A and cell growth was
monitored. (D) Viability of the anaerobic nonviable mutants. Heme-
deﬁcient cells of the indicated genotype were cultivated as de-
scribed for A; aliquots were diluted and plated on solid rich media
containing cholesterol. The number of colony-forming units per OD
unit of culture over time is shown. Mutants are grouped into func-
tional classes.
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(our unpublished data). Moreover, ATP levels in the 33
heme-deﬁcient mutants grown for 48 h in cholesterol media
were comparable with that of a heme-deﬁcient wild-type
(our unpublished data). Together, these data indicate that
the heme-deﬁcient mutants, despite their possible defect in
lipid uptake, reached stationary phase within 48 h of growth
in cholesterol media and that they remained energized and
fully viable during this time.
Biochemical Characterization of a Sterol Uptake Defect
To directly examine cholesterol uptake and/or transport,
heme-deﬁcient wild-type cells were grown in the presence
of [14C]cholesterol for 48 h, and uptake and esteriﬁcation of
the cholesterol were quantiﬁed by TLC analysis of radiola-
beled lipids. Under these conditions, the radiolabeled cho-
lesterol was efﬁciently taken up and incorporated into steryl
esters (Figure 4). Only little uptake and esteriﬁcation of
[14C]cholesterol was seen if the cells were cultivated with
ALA, consistent with exclusion of sterols under aerobic con-
ditions. Sterol uptake was dependent on the ABC transport-
ers Aus1p and Pdr11p, because it was greatly reduced in an
aus1 pdr11 hem1 triple mutant (Wilcox et al., 2002; Li and
Prinz, 2004) (Figure 4). Esteriﬁcation of the radiolabeled
cholesterol was dependent on the two ER-localized acyl
CoA:cholesterol acyltransferases (ACATs), Are1p and
Are2p, because no steryl esters were formed in an are1
are2 hem1 triple mutant (Yang et al., 1996; Yu et al., 1996)
(Figure 4). These experiments thus indicate that sterol up-
take under heme deﬁciency was dependent on the same
factors that affect sterol uptake in cells expressing the hy-
permorphic allele of UPC2 or in cells overexpressing SUT1
(Wilcox et al., 2002; Alimardani et al., 2004; Li and Prinz,
2004).
Next, we examined sterol uptake by the anaerobic nonvi-
able mutants. This analysis revealed greatly reduced levels
of both free and esteriﬁed [14C]cholesterol in drs2, bur2,
atp1, gup1, and yjr120mutant cells, indicating that these
mutants are strongly deﬁcient in uptake and esteriﬁcation of
the radiolabeled cholesterol (Figure 5). Mutations in HOM6,
TKL1, RPL1b, PHO85, ACO1, ATP2, ATP11, ATP12, CAT5,
MGM101, and UGO1, in contrast, resulted in intermediate
levels of free cholesterol but reduced levels of esteriﬁed
sterols (Figure 5). On the contrary, a deletion of ROX3 re-
sulted in signiﬁcantly elevated levels of esteriﬁed sterols.
Together, the sterol uptake analyses indicate that 17 of the 30
mutants tested in this in vivo cholesterol uptake assay dis-
played defects in sterol homeostasis under auxotrophic con-
ditions.
Visualization of Cholesterol Uptake Defects with
NBD-Cholesterol
To visualize a defect in cholesterol uptake/trafﬁcking of the
mutants under heme-deﬁcient conditions and to identify
possible transport phenotypes, the intracellular distribution
of cholesterol was examined using a ﬂuorescently labeled
cholesterol derivative, NBD-cholesterol (Mukherjee and
Chattopadhyay, 1996; Sparrow et al., 1999). Localization
studies using ﬂuorescently labeled lipid analogues are ham-
pered by the fact that the lipid is chemically modiﬁed and
thus may behave aberrantly. However, in our hands, the
NBD-labeled cholesterol represented the biochemically
characterized sterol distribution pattern more uniformly,
faithfully, and reproducibly than did staining with ﬁlipin, a
ﬂuorescent polyene. To stain cells with NBD-cholesterol,
heme-deﬁcient mutants were cultivated in media containing
a 1:1 mixture of unlabeled cholesterol and NBD-cholesterol
for 24 h. Under these conditions, NBD-cholesterol supported
growth even when added without the unlabeled cholesterol,
indicating that it is not toxic to the cells. Uptake of NBD-
cholesterol paralleled that of [14C]cholesterol over a 24-h
period. As observed in mammalian cells, the NBD-choles-
terol was even metabolized to steryl esters as indicated by
the appearance of a more hydrophobic ﬂuorescent deriva-
tive that was absent in an esteriﬁcation deﬁcient are1 are2
Figure 4. Uptake and esteriﬁcation of [14C]cholesterol in heme-
deﬁcient cells. Heme-deﬁcient cells of the indicated genotype were
grown in the presence of [14C]cholesterol and Tween 80 for 48 h at
24°C. Equal OD units of cells were harvested, lipids were extracted,
separated by TLC, and [14C]cholesterol in the free and esteriﬁed
sterol fraction was quantiﬁed by radioscanning. Values represent
mean and SD of two independent experiments. (A) Example of a
TLC plate showing uptake of [14C]cholesterol and its incorporation
into steryl esters in hem1 (YRS1707) grown in the presence (ALA)
or absence of ALA (ALA), in aus1 pdr11 hem1 (YRS1962), and
in are1 are2 hem1 (YRS1851) triple mutant cells. The position of
[14C]cholesterol in the free and esteriﬁed sterol fraction is indicated
to the right. Chol, free cholesterol; STE, steryl ester. (B) Quantiﬁca-
tion of [14C]cholesterol uptake (sterol) and incorporation into steryl
esters (STE) in the heme-deﬁcient cells shown in A.
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hem1 triple mutant (Sparrow et al., 1999) (Figure 6A). The
band labeled by an asterisk in Figure 6A was identiﬁed as an
acetylated form of NBD-cholesterol, because it is absent in a
mutant lacking ATF2, which encodes an alcohol acetyltrans-
ferase that has been shown to acetylate the steroid preg-
nenolone (Cauet et al., 1999). Although an aus1 pdr11
hem1 triple mutant displayed levels of free NBD-choles-
terol that were comparable with wild-type cells, it failed to
metabolize the ﬂuorescent cholesterol, indicating that the
free NBD-cholesterol observed in the lipid extract of these
cells may be because of adherence of the label to the cells
rather than due to bona ﬁde uptake (Figure 6A).
When examined by ﬂuorescence microscopy, the heme-
deﬁcient cells cultivated in the presence of NBD-cholesterol
for 24 h exhibited uniform ring staining at the cell periphery,
corresponding to plasma membrane, and staining of intra-
cellular punctuate structures (Figure 6B). Staining by NBD-
cholesterol was dependent on the heme deﬁciency because it
was absent when cells were supplemented with ALA. Up-
take of NBD-cholesterol was dependent on Aus1p Pdr11p,
because an aus1 pdr11 hem1 triple mutant displayed
only very weak plasma membrane staining, indicating that
the NBD-cholesterol that adheres to these cells does not
reach a hydrophobic environment, which is important to
induce a large Stoke’s shift in NBD ﬂuorescence. The ester-
iﬁcation-deﬁcient are1 are2 hem1 triple mutant, in con-
trast, displayed normal staining of the plasma membrane
but no staining of intracellular punctuate structures (Figure
6B). The fact that the NBD-cholesterol localization in an
atf2 mutant is the same as that in wild-type cells indicates
that the acetylated NBD-cholesterol does not signiﬁcantly
perturb the staining in wild-type cells. The punctuate struc-
tures that were stained with NBD-cholesterol in wild-type
Figure 5. Uptake and esteriﬁcation of [14C]cholesterol in the an-
aerobic nonviable mutants. Heme-deﬁcient cells of the indicated
genotype were grown in the presence of [14C]cholesterol and Tween
80 for 48 h at 24°C. Equal OD units of cells were harvested, lipids
were extracted, separated by TLC, and [14C]cholesterol in the free
and esteriﬁed sterol fraction (STE) was quantiﬁed by radioscanning.
Values are expressed as percentage relative to heme-deﬁcient wild-
type cells. They represent mean and standard deviations of two
independent experiments. Mutants are grouped into functional
classes as shown in Table 2.
Figure 6. Uptake, metabolic conversion, and subcellular distribu-
tion of NBD-cholesterol in heme-deﬁcient cells. (A) Uptake and
esteriﬁcation of [14C]cholesterol compared with NBD-cholesterol.
hem1 (YRS1707), are1 are2 hem1 (YRS1851), and aus1 pdr11
hem1 (YRS1962) mutant cells were cultivated in presence of either
[14C]cholesterol or NBD-cholesterol and aliquots were removed af-
ter 0 or 24 h of incubation. Lipids were separated by TLC and
visualized by phosphorimaging or ﬂuorescence. The position of free
(Chol) and esteriﬁed sterol (STE) is indicated to the right. The
asterisk indicates the position of acetylated NBD-cholesterol, which
is absent in an atf2 hem1 mutant (YRS2135). (B) Subcellular dis-
tribution of NBD-cholesterol. hem1 (YRS1707) mutant cells were
incubated with NBD-cholesterol for 24 h either in the absence or
presence of ALA and examined by ﬂuorescence microscopy. Plasma
membrane and lipid particle staining is indicated by arrows and
arrowheads, respectively. The distribution of NBD-cholesterol in an
uptake deﬁcient aus1 pdr11 hem1 (YRS1962), esteriﬁcation deﬁ-
cient are1 are2 hem1 (YRS1851), or acetylation deﬁcient atf2
hem1 (YRS2135) mutant is shown to the right. All pictures were
recorded with the same exposure settings and processed to main-
tain differences in intensity using Photoshop. Nomarski view of the
same visual ﬁelds is shown below. Bar, 5 m. (C) Lipid particle
staining by NBD-cholesterol. A hem1 mutant expressing an RFP-
tagged Erg6p (YRS2114) as marker for lipid particles was incubated
with NBD-cholesterol for 24 h. The distribution of NBD-cholesterol
and that of Erg6p-RFP were recorded by ﬂuorescence microscopy.
Colocalization of NBD-cholesterol and Erg6p-RFP in intracellular
lipid particles is indicated by arrowheads. Nomarski view of the
same visual ﬁeld is shown to the right. Bar, 5 m.
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cells corresponded to lipid particles as they colocalized with
Erg6p-red ﬂuorescent protein (RFP), a marker protein for
lipid particles (Figure 6C). These results thus indicate that
NBD-cholesterol was efﬁciently taken up, converted to steryl
esters, and incorporated into lipid particles in heme-deﬁ-
cient cells, indicating that it mimics unlabeled cholesterol
and thus could serve as a valuable tool to study sterol
uptake and transport in yeast.
Examination of the distribution of NBD-cholesterol in the
heme-deﬁcient mutant collection revealed low levels of
plasma membrane and lipid particle staining in drs2,
bur2, gup1, and yjr120 (Figure 7). Mutations in HOM6,
TKL1, RPL1b, PHO85, ACO1, ATP1, ATP2, ATP11, ATP12,
CAT5, MGM101, and UGO1, in contrast, resulted in inter-
mediate levels of plasma membrane staining but only weak
staining of lipid particles. Mutants that displayed no or
weak staining of lipid particles had apparently normal lipid
particles when stained with Nile red, a vital dye that specif-
ically stains neutral lipids (our unpublished data), indicating
that the biogenesis of lipid particles was not generally af-
fected in these mutants. rox3, in contrast, exhibited stron-
ger staining of the plasma membrane and lipid particles,
consistent with the elevated uptake and esteriﬁcation of the
radiolabeled cholesterol observed in this mutant (Figure 7).
mgm101 displayed staining of a single large punctuate
structure whose identity is unknown. Together, the analysis
of the uptake and intracellular distribution of the ﬂuorescent
NBD-cholesterol indicate that drs2, bur2, gup1, and
yjr120 are as strongly affected in sterol uptake as is an
aus1 pdr11mutant and that these mutations seem to affect
the incorporation of NBD-cholesterol into the plasma mem-
brane.
Morphological Analysis of Heme-deﬁcient Mutants
To identify possible morphological alterations that may ac-
company the defect in sterol uptake in some of the mutants,
heme-deﬁcient cells were grown in the presence of choles-
terol for 24 h and then ﬁxed and prepared for examination
by transmission electron microscopy. This analysis revealed
unusual, membrane enclosed, electron-dense structures in
aus1 pdr11, aco1, atp1, atp2, atp11, atp12, mgm101,
ugo1, and yjr120 (Figure 8). Similar structures have been
observed previously in cells lacking a mitochondrial matrix
protease and may represent aggregated mitochondrial pro-
teins that accumulate in the absence of intramitochondrial
proteolysis (Suzuki et al., 1994).
Analysis of the Subcellular Distribution of Cholesterol in
Heme-deﬁcient Uptake Mutants
To examine whether the sterol uptake mutants already block
uptake of the radiolabeled sterol at the plasma membrane, as
suggested by the NBD-cholesterol distribution, heme-deﬁ-
cient cells were grown in the presence of [14C]cholesterol for
24 h, and the subcellular distribution of the radiolabeled
cholesterol was analyzed by fractionation on an Accudenz
density gradient. Lipids from individual gradient fractions
Figure 7. Subcellular localization of NBD-cholesterol in the anaer-
obic nonviable mutants. Heme-deﬁcient cells of the indicated geno-
type were grown in the presence of NBD-cholesterol for 24 h at
24°C, and NBD-cholesterol localization was examined by ﬂuores-
cence microscopy using identical exposure settings. Bar, 5 m. Figure 8. Morphological analysis of the anaerobic nonviable mu-
tants. Heme-deﬁcient cells of the indicated genotype were grown in
the presence of cholesterol and Tween 80 for 24 h at 24°C, ﬁxed, and
examined by transmission electron microscopy. The presence and
position of unusual structures is indicated by arrows. Bar, 1 m.
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were extracted, separated on TLC, and levels of free
[14C]cholesterol were quantiﬁed. In heme-deﬁcient wild-
type cells, the radiolabeled free cholesterol was greatly en-
riched in a peak of the gradient, centering around fraction 8
(Figure 9A). The same fraction was enriched in two plasma
membrane markers, the proton pumping ATPase Pma1p
and the GPI-anchored Gas1p, but it also contained signiﬁ-
cant levels of the ER marker Sec61p and the mitochondrial
porin. The proﬁle of the [14C]cholesterol distribution, how-
ever, closely matched that of the plasma membrane markers,
indicating that the sterol peak is largely due to plasma
membrane-localized free cholesterol (Figure 9B).
In contrast to the heme-deﬁcient wild-type, the aus1
pdr11 mutant incorporated only very little radiolabeled
cholesterol into its membranes with a small peak in fraction
9 of the gradient, indicating that this mutant is deﬁcient
already in the uptake step of cholesterol at the plasma mem-
brane (Figure 9A).
Fractionation of some of the heme-deﬁcient uptake mu-
tants revealed essentially two classes of proﬁles. bur2,
drs2, and gup1 showed low levels of uptake with a ﬂat
distribution over the gradient fractions, suggesting that
these mutants affect an early step in uptake, resulting in low
levels of free sterols in the plasma membrane (Figure 9C).
pho85, mgm101, and hom6, in contrast, displayed higher
levels of uptake with a discernible enrichment of the free
sterol in fractions 7–9 of the gradient, suggesting that these
mutants may be compromised in the efﬁciency of the uptake
process or in the distribution of the sterol that has been taken
up.
Sterol Uptake Mutants Affect the Expression and
Localization of the ABC Transporters Aus1p and Pdr11p
Because Aus1p and Pdr11p are two components known to
be required for sterol uptake under anaerobic conditions, we
examined whether the uptake mutants that we have isolated
affect sterol uptake through Aus1p or Pdr11p (Wilcox et al.,
2002; Alimardani et al., 2004). Therefore, we ﬁrst examined
the subcellular localization of functional GFP-tagged ver-
sions of these two ABC transporters in our sterol uptake
mutants (Figure 10A). This analysis revealed that many of
the mutants, particularly tkl1, rpl1b, drs2, bur2, pho85,
aco1, atp2, atp12, cat5, mgm101, ugo1, gup1, and
yjr120 displayed an increased GFP ﬂuorescence in internal
structures, which were identiﬁable as vacuoles. The in-
creased staining of internal structures was frequently ac-
companied by a reduced staining of the plasma membrane,
indicating that the ABC transporters in these mutants might
either be unstable upon arrival at the cell surface or mistar-
geted to the vacuole during surface transport. The steady-
state levels of these proteins were then examined more
quantitatively by Western blot analysis (Figure 10B). This
analysis revealed large differences in the levels of Aus1p-
GFP, which migrated as multiple bands above 180 kDa, in
the different mutants. The identity of the different bands is
unknown, but it is possible that they are due to the forma-
tion of complexes that partially resist dissociation by SDS or
represent polyubiquitin conjugates. Aus1p-GFP levels were
strongly elevated in drs2, pho85, aco1, and atp12, i.e.,
in mutants that also showed internal GFP staining. hom6,
bur2, atp1, atp2, atp11, and cat5, in contrast, dis-
played reduced levels of Aus1p-GFP compared with the
hem1 mutant. Levels of Pdr11p-GFP were generally
lower than that of Aus1p-GFP, but the full-length protein
was detectable in all of the mutants. These data thus
indicate that many of the sterol uptake mutants affect
steady-state levels and localization of at least one of the
two ABC transporters, Aus1p and Pdr11p. To examine
whether a reduced expression of Aus1p could account for
the sterol uptake defect, we tested whether overexpres-
sion of Aus1p would rescue growth of the sterol uptake
mutants on media containing cholesterol. Therefore, the
heme-deﬁcient mutants were transformed with a high-
copy number plasmid that confers expression of AUS1
from a strong constitutive PMA1 promoter (Wilcox et al.,
Figure 9. Biochemical characterization of the subcellular distribu-
tion of free [14C]cholesterol. (A) hem1 (YRS1707) and hem1 aus1
pdr11 (YRS1962) mutant cells were grown in the presence of
[14C]cholesterol for 24 h at 24°C. Equal OD units of cells were
harvested, and membranes were separated on an Accudenz density
gradient. Fractions were collected, lipids were extracted and sepa-
rated by TLC, and free sterols were quantiﬁed by radioscanning. (B)
Distribution of marker proteins. Membranes from hem1 (YRS1707)
mutant cells grown in cholesterol were fractionated on an Accudenz
density gradient, and the distribution of marker proteins was ex-
amined by Western blotting with antibodies against the proteins
indicated. Organelles are indicated as follows: PM, plasma mem-
brane; LP, lipid particles; VAC, vacuole; and Mito, mitochondria.
(C) Distribution of free cholesterol in anaerobic nonviable mutants.
Strains of the indicated genotype were cultivated as in A, mem-
branes were fractionated on an Accudenz gradient, lipids were
extracted and separated by TLC, and the distribution of free
[14C]cholesterol was determined by radioscanning.
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2002; Alimardani et al., 2004). Growth analysis of the
resulting strains on media containing cholesterol, how-
ever, revealed that none of the mutants was rescued by
the overexpression of Aus1p (our unpublished data).
These results thus suggest that the sterol uptake defect of
these mutants is independent of Aus1p and Pdr11p, either
of which is sufﬁcient for sterol uptake to proceed normally
(Wilcox et al., 2002; Alimardani et al., 2004).
DISCUSSION
This study was aimed at the identiﬁcation of novel com-
ponents required for sterol uptake by yeast. Using a
genomewide screening strategy, we ﬁrst identiﬁed genes
that are essential under anaerobic conditions, i.e., under
conditions where yeast is auxotroph for sterols. To facil-
itate the subsequent analysis of the anaerobic nonviable
mutants, they were rendered heme-deﬁcient, which al-
lowed us to examine uptake and esteriﬁcation of radiola-
beled cholesterol under more practicable aerobic condi-
tions. Consistent with the growth defect seen under
anaerobic conditions, the heme-deﬁcient mutants failed to
grow on sterol-supplemented media but were viable
when supplemented with ALA. More direct analysis of
sterol uptake/transport using radiolabeled cholesterol re-
vealed that 17 of the 30 mutants tested were deﬁcient in at
least one of the steps along a putative sterol uptake/
transport pathway. The uptake defect of these mutants
seemed to be speciﬁc for sterols because radiolabeled fatty
acids were still taken up and incorporated into lipids (our
unpublished data).
Sterol Transport through Equilibration?
Sterols may be transported by proteins, by membranes, or a
combination of the two. A putative sterol uptake and trans-
port pathway is likely to be composed of separate steps,
including uptake of the free sterol at the plasma membrane,
its internalization, and possibly recycling to the plasma
membrane, followed by the transport back to the ER, ester-
iﬁcation, and deposition into lipid particles. This back trans-
port pathway may or may not be mechanistically related to
the forward transport of sterols from the ER to the plasma
membrane that operates under aerobic conditions. The vol-
ume and possibly also the rate of the back transport, how-
ever, may be comparable with that of the forward transport
because anaerobic cells grow efﬁciently and have approxi-
mately equal levels of plasma membrane sterols as they
have steryl esters, which is also the case for aerobically
grown cells. Two recent reports have shown that transport
of sterols from the ER to the plasma membrane in yeast
cannot efﬁciently be blocked by mutations in the classical
secretory pathway (Baumann et al., 2005; Schnabl et al.,
2005). It has thus been proposed that sterol transport relies
on a “nonvesicular equilibration” of the free sterol concen-
tration between the ER and the plasma membrane (Bau-
mann et al., 2005). In this model, free sterol would be trapped
at the plasma membrane through its condensation with
sphingolipids and hence removed from the equilibrium of
the free, nonsphingolipid-associated sterol pool (Baumann et
al., 2005). Under anaerobic conditions, the back transport, in
contrast, would have to act against the high sphingolipid
concentration in the plasma membrane or would ﬁrst need
to saturate the binding capacity of the plasma membrane
sphingolipids before an equilibrium with the ER could be
established. At the ER, however, the free sterol may again be
removed from the equilibrium through its esteriﬁcation.
Thus, in principle, a similar equilibration model as proposed
for the forward transport could also account for the back
transport. Such a model would be consistent with the obser-
vation that back transport of sterols to the ER requires steryl
ester synthesis in the ER and that the rate of esteriﬁcation is
inversely proportional to the propensity of different sterols
to associate with plasma membrane lipid rafts (Li and Prinz,
2004). Thus, in both models, the free sterol would efﬁ-
ciently be removed from the equilibrium by the target
membrane, either through a direct chemical modiﬁcation,
i.e., esteriﬁcation in the ER, or through the condensation
into a lipid–lipid complex, i.e., raft formation in the
plasma membrane. Our observation that the esteriﬁcation
deﬁcient are1 are2 double mutant grows normally un-
der anaerobic or heme-depleted conditions together with
the fact that the mutant takes up normal levels of free
sterols indicates that esteriﬁcation is not required for ste-
rol incorporation into the plasma membrane, as has been
proposed by Li and Prinz (2004). The equilibration model
is complicated by the fact that under aerobic conditions,
both sterols and ceramides are synthesized in the ER, one
would thus assume that they condense already at their
site of synthesis, in which case surface delivery of sterols
should be sensitive to a block in secretion, because such a
block efﬁciently inhibits the transport-dependent matura-
tion of sphingolipids (Puoti et al., 1991). Regardless, equil-
ibration of the sterol pool between different membranes
could be mediated by close apposition of donor and target
Figure 10. Subcellular localization and steady-state levels of the
two ABC transporters Aus1p and Pdr11p in the sterol uptake mu-
tants. (A) Sterol uptake mutants expressing GFP-tagged versions of
Aus1p and Pdr11p were cultivated for 24 h in cholesterol containing
media, and the subcellular distribution of the two ABC transporters
was analyzed by ﬂuorescent microscopy. Bar, 5 m. (B) Sterol
uptake mutants were cultivated as described under A. Equal OD
units of cells were harvested, and levels of Aus1p and Pdr11p were
examined by Western blots, which were also probed for GAPDH.
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membranes, i.e., membrane contacts (Levine, 2004) or
through a protein-mediated transport of the sterols
through the aqueous phase. Based on structural consider-
ations, members of the oxysterol-binding protein (OSPB)
family are good candidates for mediating such a transport
(Im et al., 2005). Whether these OSPBs indeed transport
sterols between membranes in vivo, however, remains to
be established.
Three Classes of Sterol Uptake/Transport Mutants
The sterol transport mutants that we isolated in this
screen fell into three classes. First, defects in BUR2, DRS2,
GUP1, ATP1, and YJR120 resulted in the strongest defect
in sterol uptake. The uptake defect in these mutants is in
fact as strong as that of the aus1 pdr11 double mutant.
Similar to an aus1 pdr11 mutant, defects in BUR2,
DRS2, GUP1, ATP1, and YJR120 resulted in low levels of
both free and esteriﬁed sterols, indicating a defect early in
the pathway, most likely already in the uptake step at the
plasma membrane. Consistent with this proposition,
bur2, drs2, and gup1 mutants incorporated little NBD-
cholesterol into the plasma membrane and had low levels
of radiolabeled cholesterol incorporated into the plasma
membrane, as assessed by subcellular fractionation,
thereby, again resembling the aus1 pdr11 double mu-
tant. These observations indicate that these mutants affect
sterol incorporation into the plasma membrane, a presum-
ably early step in sterol uptake. Three of these mutants,
bur2, drs2, and gup1, are particularly interesting, be-
cause their block in sterol uptake does not seem to be
related to mitochondrial function.
BUR2 encodes a divergent cyclin that is involved in tran-
scriptional regulation through histone methylation and thus
is likely to act indirectly on the expression of factors in-
volved in sterol transport or the regulation of membrane
lipid composition (Yao et al., 2000; Laribee et al., 2005).
DRS2, in contrast, may more directly be involved in sterol
transport because it encodes a candidate aminophospho-
lipid translocase. These lipid translocases form a class of
integral membrane proteins that ﬂip ﬂuorescent- or spin-
labeled derivatives of phosphatidylserine and phosphati-
dylethanolamine from the external leaﬂet of a membrane
bilayer to the cytosolic leaﬂet and thereby maintain the lipid
asymmetry of a cell membrane. Drs2p has been localized to
the trans-Golgi complex and a lack of Drs2p affects protein
transport from that organelle (Chen et al., 1999; Gall et al.,
2002). Remarkably, translocation of phosphatidylserine in
the Golgi membrane is required for Drs2p-dependent pro-
tein transport; the precise in vivo substrate of Drs2p, how-
ever, remains to be identiﬁed (Natarajan et al., 2004). The
strong sterol uptake defect that we observe in a drs2 mu-
tant could thus be because of the protein transport defect of
that mutant, as exempliﬁed by the mistargeting of Aus1p-
GFP in drs2 (Figure 10), or, alternatively, could more di-
rectly be related to an impaired lipid asymmetry of drs2
mutant membranes that could, for example, be incompatible
with the efﬁcient absorption of sterols at the plasma mem-
brane.
GUP1, ﬁnally, encodes a polytopic integral membrane
protein that localizes to the ER and has originally been
identiﬁed as being required for glycerol uptake (Holst et al.,
2000; Neves et al., 2004a). However, cells lacking GUP1
display multiple phenotypes, apparently unrelated to glyc-
erol uptake, such as defects in bipolar bud site selection,
defects in protein sorting to the vacuole, and changes in
telomere length (Ni and Snyder, 2001; Bonangelino et al.,
2002; Askree et al., 2004). The fact that a bona ﬁde glycerol
symporter, which localizes to the plasma membrane has
recently been identiﬁed suggests that the defect of gup1 in
glycerol uptake may be more indirect (Ferreira et al., 2005).
Interestingly, however, Gup1p belongs to the superfamily of
membrane-bound O-acyl transferases, which also include
Are1p and Are2p, and as such may be more directly in-
volved in lipid metabolism or protein lipidation (Hofmann,
2000; Neves et al., 2004b).
The second class of mutants displayed intermediate
levels of free sterols, i.e., between 30 and 70% of that
typically found in wild-type cells, and low levels of steryl
esters. This class contains hom6, tkl1, rpl1b, pho85,
and the majority of the mitochondrial mutants, i.e., aco1,
atp2, atp11, atp12, cat5, mgm101, and ugo1. These
mutants had normal looking lipid particles when stained
with Nile red and wild-type levels of ACAT activity when
assayed in vivo or in vitro (our unpublished data) (Yang
et al., 1996; Chang et al., 1997), suggesting that cholesterol
availability in the ER membrane, rather than a reduced
activity of the acyl CoA:cholesterol acyltransferase itself,
is likely to account for the low levels of steryl esters in
these cells. Consistent with this proposition, pho85,
mgm101, and hom6 had reduced levels of plasma mem-
brane sterols, but a normal looking proﬁle, when fraction-
ated on a density gradient.
The third class of mutants that can be distinguished based
on the levels of cholesterol they take up and esterify is
represented by rox3. ROX3 mutants had elevated levels of
esteriﬁed sterols. Rox3p is part of the RNA polymerase II
transcription mediator complex, suggesting that the effects
of Rox3p on the cellular level of free and esteriﬁed sterols are
more indirect (Myers et al., 1998).
Although the identity of the mutants isolated in this
screen does not yet reveal any molecular mechanism of
the sterol uptake and transport pathway that is operating
under anaerobic conditions, they clearly indicate that this
pathway is directly or indirectly affected by a mitochon-
drial function.
A Function of Mitochondria in Sterol Uptake/Transport
The largest class of mutants that we isolated in this screen
contains genes known to be required for mitochondrial
functions. Of 10 anaerobic nonviable mutants in this
group, eight displayed defects in sterol uptake/transport.
Four of these, atp1, atp2, atp11, and atp12, directly
affect the biogenesis of the soluble F1 sector of the F1F0
ATP synthase. Mutations in the F1 ATPase are known to
result in an anaerobic nonviable phenotype, and these
mutants are termed “petite negative,” i.e., they are lethal
in a respiratory deﬁcient background even when grown
on glucose, indicating that the lack of the ATPase can only
be tolerated if the mitochondrial electron transport chain
is functional. The petite negative phenotype of these AT-
Pase mutants has been rationalized by the hypothesis that
the ATPase activity of F1 is required to maintain an
essential electrochemical gradient across the inner mito-
chondrial membrane by converting ATP4 to ADP3  Pi
(Lefebvre-Legendre et al., 2003). Although this would ex-
plain why the ATPase mutants are nonviable under an-
aerobic conditions or in a heme-deﬁcient background, it
does not account for the deﬁciency of these mutants to
take up sterols.
Yme1, an ATP- and metal-dependent protease associated
with the mitochondrial inner membrane, is also required for
viability in a respiratory-deﬁcient background (Thorsness et
al., 1993). Deletion of YME1, however, does not affect sterol
uptake, indicating that the sterol uptake defect of the mito-
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chondrial mutants is independent of their petite negative
phenotype. Similarly, strains with deletions or such that
completely lack the mitochondrial genome (rho and rho°)
have no growth defect under anaerobic conditions (our un-
published data), indicating that sterol uptake is independent
of the presence of a mitochondrial genome and hence is not
affected by the lack of F0 subunits of the ATPase, some of
which are mitochondrially encoded.
A deﬁcient electron transport chain, as caused by the
heme mutation, combined with an inability to generate an
alternative membrane potential, because a mutation in the
ATPase, is thus likely to deenergize the mitochondria and
hence arrest its functions and biogenesis. Energy depletion
of mitochondria has been reported to affect both transport of
ER-synthesized ergosterol to the plasma membrane and up-
take of exogenously supplied cholesterol (Hunakova et al.,
1997). In addition, energy depletion may induce the collapse
of the matrix and formation of electron-dense inclusions.
These ultrastructural changes, however, are unlikely to ac-
count for the block in sterol uptake, because we found that
pim1/lon1 mutant cells are viable under anaerobic condi-
tions (our unpublished data).
The observation, that electron-dense structures are also
apparent in an aus1 pdr11 mutant, which lacks two ABC
transporters that have been localized to the plasma mem-
brane and thus have no obvious relation to mitochondrial
functions (Li and Prinz, 2004), rather suggests that the ab-
errant mitochondria could be because of a defect of these
cells to take up sterols. The inner mitochondrial membrane
is relatively rich in ergosterol, but the total and the mito-
chondrial ergosterol contents drop up to fourfold in anaer-
obic cells, even when supplemented with ergosterol (Jollow
et al., 1968; Paltauf and Schatz, 1969; Schneiter et al., 1999).
Such a reduced mitochondrial sterol content is known to
affect the activity of the adenine nucleotide transporter in the
inner mitochondrial membrane, leading to decreased intra-
mitochondrial ATP levels and a decreased mitochondrial
macromolecular synthesis (Haslam et al., 1977). Reduced
ATP levels, in turn, are likely to inhibit the ATP-dependent
mitochondrial protease Pim1/Lon1 and thereby might re-
sult in a phenotype characteristic for the protease deﬁcient
mutant (van Dijl et al., 1998). Thus, it seems reasonable to
suggest that the electron-dense mitochondrial inclusions are
a consequence rather than a cause of the reduced sterol
uptake in these mutants. In this case, however, these struc-
tures should be visible in all the uptake mutants and may
even be diagnostic for a sterol uptake defect, unless some of
the mutants arrest at a stage that precedes the mitochondrial
collapse. Thus, a direct role of membrane sterols in mito-
chondrial ATP import would explain the altered mitochon-
drial structures that are observed in many of the sterol
uptake mutants, but it does not explain why the presumably
deenergized mitochondria affect sterol uptake.
Even under anaerobic conditions, mitochondrial dysfunc-
tions are likely to affect many different cellular functions,
such as calcium and iron homeostasis, or modify the expres-
sion of nuclear genes, each of which could directly or indi-
rectly affect sterol transport (Bianchi et al., 2004; Butow and
Avadhani, 2004; Lill and Mu¨hlenhoff, 2005). Alternatively, in
vertebrate and insect cells, mitochondria themselves are
known to be important for sterol metabolism, because they
harbor the cytochrome P450 side chain cleavage enzyme that
converts cholesterol to pregnenolone, which is then further
metabolized to steroids (Miller, 1995). Remarkably, heterol-
ogous expression of P450 side chain cleavage activity in
yeast mitochondria results in the conversion of endog-
enously synthesized sterols to pregnenolone, thus indicating
that sterols are accessible and thus transported to the P450
system in the matrix site of the inner mitochondrial mem-
brane (Duport et al., 1998). Transport routes for sterols from
the ER or the plasma membrane to mitochondria thus seem
to have evolved at some point. Our results would indicate
that such routes may already be present in yeast and that
they could be important for sterol uptake under anaerobic
conditions.
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